Research Paper
Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity
Article first published online: 23 JUL 2012
DOI: 10.1111/j.1365-2141.2012.09225.x
© 2012 Blackwell Publishing Ltd
Additional Information
How to Cite
Toor, A. A., Payne, K. K., Chung, H. M., Sabo, R. T., Hazlett, A. F., Kmieciak, M., Sanford, K., Williams, D. C., Clark, W. B., Roberts, C. H., McCarty, J. M. and Manjili, M. H. (2012), Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity. British Journal of Haematology, 158: 700–711. doi: 10.1111/j.1365-2141.2012.09225.x
Publication History
- Issue published online: 28 AUG 2012
- Article first published online: 23 JUL 2012
- Manuscript Accepted: 29 MAY 2012
- Manuscript Received: 8 APR 2012
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk, Clinical and Developmental Immunology, 2012, 2012, 1

1365-2141/asset/olbannerleft.gif?v=1&s=2237887a0dba115836e329b1c5824f93749b814b)
1365-2141/asset/olbannerright.gif?v=1&s=01b5795d608a5571b530fcd8eb300f01b48de3b2)
